Patent details

Basic Information

Publication number:

EP2503338

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP120025028

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CD73 as a biomarker for monitoring development of diseases and assessing the efficacy of therapies

French Title of Invention:

CD73 comme biomarqueur pour surveiller le développement de maladies et évaluer l'efficacité des thérapies

German Title of Invention:

CD73 als Biomarker zur Überwachung der Entwicklung von Krankheiten und zum Testen der Wirksamkeit von Therapien

SPC Number:

Dates

Filing date:

15/10/2008

Grant date:

24/12/2014

EP Publication Date:

24/12/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/09/2012

EP B1 Publication Date:

24/12/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

15/10/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/10/2008

 

 

Name:

Faron Pharmaceuticals OY

Address:

Tykistökatu 6 B, 20520 Turku, Finland (FI)

Inventor

1

Name:

Salmi Marko

Address:

Finland (FI)

2

Name:

Jalkanen Sirpa

Address:

Finland (FI)

3

Name:

jalkanen Markku

Address:

France (FR)

Priority

Priority Number:

20070795

Priority Date:

24/10/2007

Priority Country:

Finland (FI)

Classification

Main IPC Class:

G01N 33/573;

Annual Fees

Annual Fee Due Date:

30/04/2025

Annual Fee Number:

17

Annual Fee Amount:

246 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

16/10/2023

Last Annual Fee Paid Number:

16

Last Annual Fee Paid Amount:

230 Euro

Payer:

CPA GLOBAL (PATRAFEE) AB

Filing date	Document type	Number of pages